Delivery Order SPE2DB22D2206-SPE2DB24FFW29
- Not listed
- This federal contract award, valued at $2,801.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of an Advair HFA 115-21 MCG Inhaler, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,342.68 fixed-price contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a specialty medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award, valued at $2,135.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG inhalers, a specialty medication product, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $2,413.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of an Advair HFA 115-21 MCG Inhaler, a prescription medication, with a completion date of December 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,023.30 firm fixed-price delivery order covers the supply of Advair HFA 230-21 MCG Inhaler, a pharmaceutical product used to treat respiratory conditions. This award is under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through December...
- This federal contract award is a $9,167.13 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the supply of Advair HFA 115-21 MCG Inhaler, a prescription medication, to support federal healthcare programs. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. It is associated with Amerisourcebergen's...
- This federal contract award, valued at $2,687.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of June 13, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $18,359.82, is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December...
- This federal contract award, valued at $1,104.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award is for the delivery of Advair HFA 230-21 mcg inhalers, a prescription medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award, valued at $6,325.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFW29Delivery Order
This federal contract award, valued at $86,769.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a specialty medication, to support military and federal healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA, enabling efficient procurement for the Department of Defense and other federal agencies. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.8k | 2/29/24 |